Clinical Trials Directory

Trials / Completed

CompletedNCT02230449

Identifying Expression Markers of Cumulus Cells to Identify Oocyte Developmental Potential Through a Maturation Analysis

Identifying Markers of Oocyte Competence Through a Maturation Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Memorial Sisli Hospital, Istanbul · Academic / Other
Sex
Female
Age
18 Years – 39 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to analyze the expression of genes and microRNAs potentially involved in oocyte competence in follicles of different sizes (\<17mm and ≥17mm) at the time of oocyte pick-up.

Detailed description

In ART, one of the major obstacles encountered in some patients is the wide variation in the follicular size at the oocyte pick-up day and consequently, the number of available mature oocytes and the number of competent embryos for implantation. The follicular size at the day of oocyte pick-up reflects the synchronicity of the individual follicular responsiveness to FSH. For successful preimplantation development of an embryo, the oocyte must contain all necessary maternal factors. Two of these factors are specific mRNA transcripts (GDF9, PTX3, HAS2, PTGS2, TNFAIP6) and microRNA (miR-224). For each Cumulus Oocyte Complex, the evaluation of embryo development and morphokinetics will be correlated with the expression and implantation data to identify a quantitative biomarker to predict the embryo with the highest chance of implantation in patients. Experimental Design: 1. \- Collection of Cumulus Oocyte Complex (COC) from patients 2. \- Separation of oocytes according to the size of the follicule they have been retrieved from (\<17mm; ≥17mm) 3. \- Isolation of mRNA from both groups of cumulus cells 4. \- Expression studies, qRT-PCR (GDF9, PTX3, HAS2, PTGS2, TNFAIP6) 5. \- Analysis of miR-224, a negative regulator of cumulus expansion via PTX3 6. \- Time-lapse culture \& evaluation of morphokinetics

Conditions

Timeline

Start date
2014-08-01
Primary completion
2016-06-01
Completion
2016-09-01
First posted
2014-09-03
Last updated
2017-09-05

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02230449. Inclusion in this directory is not an endorsement.